For renal impairment, although most GLP-1 agents have minimal renal clearance, impaired kidney function increases the risk of adverse events such as dehydration from vomiting or decreased drug clearance in polypharmacy
MHRA-licensed alternatives for weight management including semaglutide (Wegovy), liraglutide (Saxenda), orlistat, and tirzepatide (Mounjaro) have well-characterised safety profiles and NICE eligibility criteria
KLOW vs
Trong khi , mt nghin cu ca Php ch ra rng cc loi thuc chng vim khng steroid (NSAID) s cho hiu qu tt nht khi s dng trc khi cn au bt u t 4 n 8 ting
Unlike the consistent inhibition seen with GLP-1 analogues, Ex-4 has shown variable effects on adipogenic differentiation
People with absorption disorders, older adults, individuals following strict vegan diets and those with certain medical conditions may be at increased risk